The SU2C–American Cancer Society (ACS) Lung Cancer Dream Team has established a collaborative, scientifically rigorous, multidisciplinary program that brings together two highly promising treatment approaches: targeted therapy―in this case targeting the KRAS gene―and immunotherapy. This combined approach should lead to novel treatments that will markedly improve outcomes for KRAS-mutant non-small cell lung cancer patients.
- Who We Are
Stand Up To Cancer works relentlessly to offer the newest, most effective, and most promising cancer treatments to patients quickly by bringing together the best minds to collaborate, innovate, and share cancer research.
Visit Who We Are - What We Do
Stand Up To Cancer enables scientific breakthroughs by funding collaborative, multidisciplinary, multi-institutional scientific cancer research teams and investigators. Thanks to the support of our dedicated partners and the entertainment community, SU2C is able to bring widespread attention to cancer research and treatments.
Visit What We Do - Take Action
We’re all in this together! Learn how to get involved and make a monumental impact. Join our community of passionate supporters who are committed to helping patients gain rapid access to better treatments.
Visit Take Action - Clinical Trials
Research is changing the way cancer is being treated. If you’ve been diagnosed with cancer, a clinical trial may offer access to the latest and most promising science, while helping to light the path for future survivors.
Visit Clinical Trials - Research
Stand Up To Cancer was created to accelerate groundbreaking cancer research that will get promising new cancer treatments to patients quickly. We won’t stop until every cancer patient is a long-term cancer survivor.
Visit Research - For Patients & Caregivers
We understand the challenges a diagnosis can bring. Browse through our list of patient and caregiver resources to help you throughout your cancer journey, and learn more about clinical trials.
Visit For Patients & Caregivers
